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ABSTRACT
36
Objectives: To examine outcome reporting bias of systematic reviews registered in PROSPERO.
37
Study Design and Setting: Retrospective cohort study. The primary outcomes from systematic 38 review publications were compared with those reported in the corresponding PROSPERO 39 records; discrepancies in the primary outcomes were assessed as upgrades, additions, omissions 40 or downgrades. Relative risks (RR) and 95% confidence intervals (CI) were calculated to 41 determine the likelihood of having a change in primary outcome when the meta-analysis result 42 was favourable and statistically significant.
43
Results: 96 systematic reviews were published. A discrepancy in the primary outcome occurred 44 in 32% of the included reviews and 39% of the reviews did not explicitly specify a primary 45 outcome(s); 6% of the primary outcomes were omitted. There was no significant increased risk 46 of adding/upgrading (RR 2.14, 95% CI 0.53 to 8.63) or decreased risk of downgrading (RR 0.76, 47 
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What is new?
Key finding
• Many systematic reviews that are registered in PROSPERO have discrepancies in primary outcomes between their record and review publication.
What this study adds to what is known?
• This is the first study to examine outcome reporting bias using the PROSPERO register, a database for prospectively registering systematic reviews that was established in 2011.
• Previous studies have compared outcomes reported in Cochrane reviews to those reported in the corresponding review protocols. These studies found that more than 1/3 of published systematic reviews had a discrepancy between the outcomes reported in the protocol versus final publication. One study found evidence of outcome reporting bias, in which statistically significant outcomes were more likely to be upgraded (i.e. promoted from secondary to primary) or added in the final publication compared to the protocol.
• We found that approximately 1/3 of published systematic reviews had a discrepancy between the outcomes reported in the PROSPERO record versus the review publication.
However, evidence of outcome reporting bias was not observed.
What is the implication, and what should change now?
• Our study suggests that non-Cochrane review authors have similar outcome reporting behaviours to Cochrane review authors. We recommend that all non-Cochrane reviews are registered with PROSPERO, review authors carefully consider the selection of primary outcomes, peer reviewers should check PROSPERO to see if there are any discrepancies between the record and review publication, and journals are encouraged to focus acceptance on registered systematic reviews.
M A N U S C R I P T
A C C E P T E D Cochrane systematic reviews. Since most published systematic reviews are not Cochrane reviews 
METHODS
87
Protocol
88
Prior to conducting this retrospective cohort study, we created a project plan, which 89 outlined our study methods. Our protocol was revised after receiving feedback from all authors.
90
The final protocol can be found in Appendix A. Since this study was not a systematic review, it 91 was not eligible to be registered with the PROSPERO repository. A data abstraction form with an explanation guide was developed (Appendix Table A) 106 and calibrated through a team exercise. Specifically, the team independently pilot-tested the 107 forms using a random sample of 10 included systematic reviews. Data abstraction did not 
Data items
113
The data items were abstracted from both the protocol details and the publication, and The overall methodological quality of the systematic reviews was assessed using the 144 Assessment of Multiple SysTemAtic Reviews (AMSTAR) tool (Appendix Table B 
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RESULTS
188
Sample of PROSPERO records
189
In November 2013, 2,426 protocol records were registered with PROSPERO and 344 190 were completed systematic reviews (Figure 1 ). Of the completed reviews, 140 were potentially 191 relevant (i.e., published or in press), and of these 44 were excluded because they were not 192 systematic reviews of interventions or the final review was not written in English (Appendix 193   Table C ). Ninety-six systematic reviews fulfilled the eligibility criteria and were subsequently 194 included (Appendix Table C Although the primary outcome was indicated in PROSPERO, which is structured to 211 separate primary and secondary outcomes, it was not explicitly reported for 37 (38.5%) of the 212 completed systematic reviews, so was derived for the purpose of our study ( 
Meta-analysis results
223
The results of 139 meta-analyses in 67 systematic reviews are presented in Appendix 224 Table E . There was no significant increased risk of adding or upgrading an outcome when the 225 meta-analysis result was favourable and statistically significant (RR 2.14, 95% CI 0.53 to 8.63), 226 which was the same result as found in our sensitivity analysis (Appendix Table F conclusion when the outcomes were added/upgraded or downgraded (Appendix Table L ). 
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DISCUSSION
246
One-third of published systematic reviews that were registered with PROSPERO had a 247 discrepancy between the primary outcome reported in their record and the primary outcome 248 reported in the review publication. Of the discrepancies, downgrading of primary outcomes was 249 most common (22%), and 6% of reviews omitted a protocol-specified primary outcome from the 250 review. In addition, 39% of reviews did not explicitly specify a primary outcome(s) in the 251 review. Although a lot of discrepancies were observed, we did not find statistically significant 252 associations between discrepant outcome reporting and having a favourable and statistically 253 significant meta-analysis result or positive conclusion. However, the small number of reviews 254 within each subgroup of discrepancy classification likely limited the statistical power to detect 255 statistically significant results. PROSPERO has now passed 5,000 registrants and repeating this 256 study is likely to yield a larger number of published systematic reviews to examine.
257
Our study is the first to measure outcome reporting bias of systematic reviews that were Our results are only generalizable to intervention reviews, as the risk of outcome 266 reporting bias in other types of reviews (e.g., diagnostic reviews) remains unknown. As well, we 267 only included non-Cochrane reviews. We considered only primary outcomes, which may have and completed systematic reviews, due to resource restraints. Due to the small number of 277 included reviews in our analyses, we were unable to examine possible sources of heterogeneity 278 that may have confounded our results or conduct sub-group analysis for outcome reporting bias 279 for systematic reviews with active comparators versus placebo, "high" versus "low" quality as 280 per the AMSTAR tool, and randomized trials versus non-randomized studies. As well, there is a 281 chance that there were more completed systematic reviews that were published but the authors of 282 the review failed to update their PROSPERO record (although they are sent 3auto-reminders to 283 update their information in PROSPERO). We were only able to include the systematic reviews 284 with meta-analyses in our statistical analysis of outcome reporting bias, which is consistent with 285 previous studies [4] [5] [6] [7] . Finally, we calculated risk ratios instead of odds ratios to compare our 286 study with previous studies conducted in this area. between the record and review publication and ensure that the author explains these. Finally, 316 journals are encouraged to focus acceptance on registered systematic reviews, as we found that 317 these are likely to be of high methodological quality.
318
Few studies have examined outcome reporting bias in systematic reviews [9] . There has 319 been no study of systematic reviews that are not registered with the Cochrane Collaboration or abstraction, appraised the quality of the articles, edited the paper, and approved the final paper.
331
MJP also analyzed the data, AB screened the records for inclusion, and HM helped clean the data 332 and resolve discrepancies. TC, LAS, SES, and DM edited the paper and approved the final paper.
333
ACT accepts full responsibility for the finished article, had access to all of the data, and 334 controlled the decision to publish. ACT affirms that this manuscript is an honest, accurate, and 335 transparent account of the study being reported; that no important aspects of the study have been 336 omitted; and that no discrepancies from the study as planned occurred. • 43 were not a systematic review of an intervention • 1 final report was not published in English
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